ImmunityBio (IBRX) Q2 2025 Earnings

12MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.2
-0.16
-0.13
-0.09

Details

Expected EPS
-0.128
Actual EPS
-0.15
Surprise EPS
-0.02
Surprise Percent
+17.19%

Description

ImmunityBio (IBRX) has reported earnings of -0.15 per share for Q2 2025.

0 Comments

Share your thoughts